Experienced in Hepatic Venoocclusive Disease with Immunodeficiency

Pramila Krishnamurthy

Denmark Hill, 
London, ENG, GB 
Experienced in Hepatic Venoocclusive Disease with Immunodeficiency
Denmark Hill, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Pramila Krishnamurthy practices in London, United Kingdom. Krishnamurthy is rated as an Experienced expert by MediFind in the treatment of Hepatic Venoocclusive Disease with Immunodeficiency. Their top areas of expertise are Myelodysplastic Syndrome (MDS), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Hepatic Venoocclusive Disease with Immunodeficiency, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 32 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hepatic Venoocclusive Disease with Immunodeficiency.

Locations

Denmark Hill, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse Who Are Eligible for High Dose Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation (ASCT)
Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse Who Are Eligible for High Dose Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation (ASCT)
Enrollment Status: Unknown
Publish Date: March 13, 2018
Intervention Type: Drug, Other
Study Drugs: DHAP, Brentuximab Vedotin
Study Phase: Phase 1

32 Total Publications

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.
Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS.
Journal: Blood advances
Published: February 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Krishnamurthy's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile